NCT05363670Phase 2Completed

Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Study sponsor: ARS Pharmaceuticals, Inc. · SPRY

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-02-02Actual
Enrollment · participants18Actual
Source updated2026-07-14Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Effect of ARS-1 versus Albuterol and placebo. After: Measure: Effect of ARS-1 Versus Albuterol and Placebo.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview